APO Research
Talk to an analyst

APO RESEARCH · REPORT

Levetiracetam

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Levetiracetam Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchLevetiracetam Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Levetiracetam Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Levetiracetam Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Levetiracetam Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Levetiracetam Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Levetiracetam market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Levetiracetam is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Levetiracetam is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Levetiracetam is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Levetiracetam include Zhejiang Jingxin Pharmaceutical, Chongqing shenghuaxi Pharmaceutical, Eisai Inc, Salubris Pharmaceuticals, Sanofi, Novartis, Pfizer, GlaxoSmithKline and UCB Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Levetiracetam market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Levetiracetam market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Levetiracetam market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Levetiracetam.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Levetiracetam market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Levetiracetam Market by Company

Zhejiang Jingxin Pharmaceutical

Chongqing shenghuaxi Pharmaceutical

Eisai Inc

Salubris Pharmaceuticals

Sanofi

Novartis

Pfizer

GlaxoSmithKline

UCB Pharma

Levetiracetam Segment by Type

Injection Solution

Tablet

Oral Liquid

Levetiracetam Segment by Application

Myoclonic Treatment

Tonic-clonic Seizures Treatment

Others

Levetiracetam Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levetiracetam market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Levetiracetam and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levetiracetam.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Levetiracetam manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Levetiracetam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Solution Table 2. Major Company of Tablet Table 3. Major Company of Oral Liquid Table 4. Global Levetiracetam Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Levetiracetam Sales by Type (2021-2026) & (k units) Table 6. Global Levetiracetam Sales Market Share in Volume by Type (2021-2026) Table 7. Global Levetiracetam Sales by Type (2021-2026) & (US$ Million) Table 8. Global Levetiracetam Sales Market Share in Value by Type (2021-2026) Table 9. Global Levetiracetam Price by Type (2021-2026) & (US$/unit) Table 10. Global Levetiracetam Sales by Type (2027-2032) & (k units) Table 11. Global Levetiracetam Sales Market Share in Volume by Type (2027-2032) Table 12. Global Levetiracetam Sales by Type (2027-2032) & (US$ Million) Table 13. Global Levetiracetam Sales Market Share in Value by Type (2027-2032) Table 14. Global Levetiracetam Price by Type (2027-2032) & (US$/unit) Table 15. North America Levetiracetam Sales by Type (2021-2026) & (k units) Table 16. North America Levetiracetam Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Levetiracetam Sales by Type (2021-2026) & (k units) Table 18. Europe Levetiracetam Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Levetiracetam Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Levetiracetam Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Levetiracetam Sales by Type (2021-2026) & (k units) Table 22. Latin America Levetiracetam Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Levetiracetam Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Levetiracetam Sales by Type (2021-2026) & (US$ Million) Table 25. Levetiracetam Industry Trends Table 26. Levetiracetam Industry Drivers Table 27. Levetiracetam Industry Opportunities and Challenges Table 28. Levetiracetam Industry Restraints Table 29. Global Levetiracetam Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Levetiracetam Revenue Market Share by Company (2021-2026) Table 31. Global Levetiracetam Sales by Company (2021-2026) & (k units) Table 32. Global Levetiracetam Sales Share by Company (2021-2026) Table 33. Global Levetiracetam Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Levetiracetam Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Levetiracetam Major Company Production Sites and Headquarters Table 36. Global Levetiracetam Company, Product Type & Application Table 37. Global Levetiracetam Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Levetiracetam by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Levetiracetam Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Levetiracetam Sales by Region (2021-2026) & (k units) Table 42. Global Levetiracetam Sales Market Share in Volume by Region (2021-2026) Table 43. Global Levetiracetam Sales by Region (2021-2026) & (US$ Million) Table 44. Global Levetiracetam Sales Market Share in Value by Region (2021-2026) Table 45. Global Levetiracetam Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Levetiracetam Sales by Region (2027-2032) & (k units) Table 47. Global Levetiracetam Sales Market Share in Volume by Region (2027-2032) Table 48. Global Levetiracetam Sales by Region (2027-2032) & (US$ Million) Table 49. Global Levetiracetam Sales Market Share in Value by Region (2027-2032) Table 50. Global Levetiracetam Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Levetiracetam Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Levetiracetam Sales by Application (2021-2026) & (k units) Table 53. Global Levetiracetam Sales Market Share in Volume by Application (2021-2026) Table 54. Global Levetiracetam Sales by Application (2021-2026) & (US$ Million) Table 55. Global Levetiracetam Sales Market Share in Value by Application (2021-2026) Table 56. Global Levetiracetam Price by Application (2021-2026) & (US$/unit) Table 57. Global Levetiracetam Sales by Application (2027-2032) & (k units) Table 58. Global Levetiracetam Sales Market Share in Volume by Application (2027-2032) Table 59. Global Levetiracetam Sales by Application (2027-2032) & (US$ Million) Table 60. Global Levetiracetam Sales Market Share in Value by Application (2027-2032) Table 61. Global Levetiracetam Price by Application (2027-2032) & (US$/unit) Table 62. North America Levetiracetam Sales by Application (2021-2026) & (k units) Table 63. North America Levetiracetam Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Levetiracetam Sales by Application (2021-2026) & (k units) Table 65. Europe Levetiracetam Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Levetiracetam Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Levetiracetam Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Levetiracetam Sales by Application (2021-2026) & (k units) Table 69. Latin America Levetiracetam Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Levetiracetam Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Levetiracetam Sales by Application (2021-2026) & (US$ Million) Table 72. Zhejiang Jingxin Pharmaceutical Company Information Table 73. Zhejiang Jingxin Pharmaceutical Business Overview Table 74. Zhejiang Jingxin Pharmaceutical Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Zhejiang Jingxin Pharmaceutical Levetiracetam Product Portfolio Table 76. Zhejiang Jingxin Pharmaceutical Recent Development Table 77. Chongqing shenghuaxi Pharmaceutical Company Information Table 78. Chongqing shenghuaxi Pharmaceutical Business Overview Table 79. Chongqing shenghuaxi Pharmaceutical Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Chongqing shenghuaxi Pharmaceutical Levetiracetam Product Portfolio Table 81. Chongqing shenghuaxi Pharmaceutical Recent Development Table 82. Eisai Inc Company Information Table 83. Eisai Inc Business Overview Table 84. Eisai Inc Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eisai Inc Levetiracetam Product Portfolio Table 86. Eisai Inc Recent Development Table 87. Salubris Pharmaceuticals Company Information Table 88. Salubris Pharmaceuticals Business Overview Table 89. Salubris Pharmaceuticals Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Salubris Pharmaceuticals Levetiracetam Product Portfolio Table 91. Salubris Pharmaceuticals Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Sanofi Levetiracetam Product Portfolio Table 96. Sanofi Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Novartis Levetiracetam Product Portfolio Table 101. Novartis Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Pfizer Levetiracetam Product Portfolio Table 106. Pfizer Recent Development Table 107. GlaxoSmithKline Company Information Table 108. GlaxoSmithKline Business Overview Table 109. GlaxoSmithKline Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. GlaxoSmithKline Levetiracetam Product Portfolio Table 111. GlaxoSmithKline Recent Development Table 112. UCB Pharma Company Information Table 113. UCB Pharma Business Overview Table 114. UCB Pharma Levetiracetam Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. UCB Pharma Levetiracetam Product Portfolio Table 116. UCB Pharma Recent Development Table 117. North America Levetiracetam Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. North America Levetiracetam Sales by Country (2021-2026) & (k units) Table 119. North America Levetiracetam Sales Market Share by Country (2021-2026) Table 120. North America Levetiracetam Sales Forecast by Country (2027-2032) & (k units) Table 121. North America Levetiracetam Sales Market Share Forecast by Country (2027-2032) Table 122. North America Levetiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Levetiracetam Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Levetiracetam Market Share by Country (2021-2026) Table 125. North America Levetiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Levetiracetam Market Share Forecast by Country (2027-2032) Table 127. Europe Levetiracetam Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Europe Levetiracetam Sales by Country (2021-2026) & (k units) Table 129. Europe Levetiracetam Sales Market Share by Country (2021-2026) Table 130. Europe Levetiracetam Sales Forecast by Country (2027-2032) & (k units) Table 131. Europe Levetiracetam Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Levetiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Levetiracetam Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Levetiracetam Market Share by Country (2021-2026) Table 135. Europe Levetiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Levetiracetam Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Levetiracetam Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Levetiracetam Sales by Country (2021-2026) & (k units) Table 139. Asia-Pacific Levetiracetam Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Levetiracetam Sales Forecast by Country (2027-2032) & (k units) Table 141. Asia-Pacific Levetiracetam Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Levetiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Levetiracetam Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Levetiracetam Market Share by Country (2021-2026) Table 145. Asia-Pacific Levetiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Levetiracetam Market Share Forecast by Country (2027-2032) Table 147. Latin America Levetiracetam Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Latin America Levetiracetam Sales by Country (2021-2026) & (k units) Table 149. Latin America Levetiracetam Sales Market Share by Country (2021-2026) Table 150. Latin America Levetiracetam Sales Forecast by Country (2027-2032) & (k units) Table 151. Latin America Levetiracetam Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Levetiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Levetiracetam Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Levetiracetam Market Share by Country (2021-2026) Table 155. Latin America Levetiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Levetiracetam Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Levetiracetam Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Levetiracetam Sales by Country (2021-2026) & (k units) Table 159. Middle East and Africa Levetiracetam Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Levetiracetam Sales Forecast by Country (2027-2032) & (k units) Table 161. Middle East and Africa Levetiracetam Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Levetiracetam Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Levetiracetam Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Levetiracetam Market Share by Country (2021-2026) Table 165. Middle East and Africa Levetiracetam Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Levetiracetam Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Levetiracetam Distributors List Table 170. Levetiracetam Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Levetiracetam Image Figure 2. Global Levetiracetam Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Levetiracetam Market Size (2021-2032) & (US$ Million) Figure 4. Global Levetiracetam Sales (2021-2032) & (k units) Figure 5. Injection Solution Image Figure 6. Global Injection Solution Sales YoY Growth (2021-2032) & (k units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (k units) Figure 9. Oral Liquid Image Figure 10. Global Oral Liquid Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Levetiracetam Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Levetiracetam Market Share by Type 2025 VS 2032 Figure 13. North America Levetiracetam Sales Market Share in Volume by Type in 2025 Figure 14. North America Levetiracetam Sales Market Share in Value by Type in 2025 Figure 15. Europe Levetiracetam Sales Market Share in Volume by Type in 2025 Figure 16. Europe Levetiracetam Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Levetiracetam Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Levetiracetam Sales Market Share in Value by Type in 2025 Figure 19. Latin America Levetiracetam Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Levetiracetam Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Levetiracetam Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Levetiracetam Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Levetiracetam Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Myoclonic Treatment Image Figure 26. Global Myoclonic Treatment Sales YoY Growth (2021-2032) & (k units) Figure 27. Tonic-clonic Seizures Treatment Image Figure 28. Global Tonic-clonic Seizures Treatment Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Levetiracetam Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Levetiracetam Market Share by Application 2025 VS 2032 Figure 33. North America Levetiracetam Sales Market Share in Volume by Application in 2025 Figure 34. North America Levetiracetam Sales Market Share in Value by Application in 2025 Figure 35. Europe Levetiracetam Sales Market Share in Volume by Application in 2025 Figure 36. Europe Levetiracetam Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Levetiracetam Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Levetiracetam Sales Market Share in Value by Application in 2025 Figure 39. Latin America Levetiracetam Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Levetiracetam Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Levetiracetam Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Levetiracetam Sales Market Share in Value by Application in 2025 Figure 43. North America Levetiracetam Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Levetiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Levetiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Levetiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Levetiracetam Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Levetiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Levetiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Levetiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Levetiracetam Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Levetiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Levetiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Levetiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Levetiracetam Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Levetiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Levetiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Levetiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Levetiracetam Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Levetiracetam Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Levetiracetam Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Levetiracetam Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Levetiracetam Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Levetiracetam Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Solution
  • Tablet
  • Oral Liquid
Applications
  • Myoclonic Treatment
  • Tonic-clonic Seizures Treatment
  • Others
Companies covered
  • Zhejiang Jingxin Pharmaceutical
  • Chongqing shenghuaxi Pharmaceutical
  • Eisai Inc
  • Salubris Pharmaceuticals
  • Sanofi
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • UCB Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Levetiracetam Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Levetiracetam Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Levetiracetam Market by Type
  6. 1.3.1 Injection Solution
  7. 1.3.2 Tablet
  8. 1.3.3 Oral Liquid
  9. 1.4 Global Levetiracetam Market Size by Type
  10. 1.4.1 Global Levetiracetam Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Levetiracetam Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Levetiracetam Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Levetiracetam Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Levetiracetam Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Levetiracetam Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Levetiracetam Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Levetiracetam Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Levetiracetam Industry Trends
  2. 2.2 Levetiracetam Industry Drivers
  3. 2.3 Levetiracetam Industry Opportunities and Challenges
  4. 2.4 Levetiracetam Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Levetiracetam Revenue (2021-2026)
  2. 3.2 Global Top Players by Levetiracetam Sales (2021-2026)
  3. 3.3 Global Top Players by Levetiracetam Price (2021-2026)
  4. 3.4 Global Levetiracetam Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Levetiracetam Major Company Production Sites & Headquarters
  6. 3.6 Global Levetiracetam Company, Product Type & Application
  7. 3.7 Global Levetiracetam Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Levetiracetam Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Levetiracetam Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Levetiracetam Tier 1, Tier 2, and Tier 3
4 Levetiracetam Regional Status and Outlook
  1. 4.1 Global Levetiracetam Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Levetiracetam Historic Market Size by Region
  3. 4.2.1 Global Levetiracetam Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Levetiracetam Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Levetiracetam Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Levetiracetam Forecasted Market Size by Region
  7. 4.3.1 Global Levetiracetam Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Levetiracetam Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Levetiracetam Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Levetiracetam by Application
  1. 5.1 Levetiracetam Market by Application
  2. 5.1.1 Myoclonic Treatment
  3. 5.1.2 Tonic-clonic Seizures Treatment
  4. 5.1.3 Others
  5. 5.2 Global Levetiracetam Market Size by Application
  6. 5.2.1 Global Levetiracetam Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Levetiracetam Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Levetiracetam Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Levetiracetam Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Levetiracetam Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Levetiracetam Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Levetiracetam Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Levetiracetam Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Jingxin Pharmaceutical
  2. 6.1.1 Zhejiang Jingxin Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Jingxin Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Jingxin Pharmaceutical Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Jingxin Pharmaceutical Levetiracetam Product Portfolio
  6. 6.1.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  7. 6.2 Chongqing shenghuaxi Pharmaceutical
  8. 6.2.1 Chongqing shenghuaxi Pharmaceutical Company Information
  9. 6.2.2 Chongqing shenghuaxi Pharmaceutical Business Overview
  10. 6.2.3 Chongqing shenghuaxi Pharmaceutical Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chongqing shenghuaxi Pharmaceutical Levetiracetam Product Portfolio
  12. 6.2.5 Chongqing shenghuaxi Pharmaceutical Recent Developments
  13. 6.3 Eisai Inc
  14. 6.3.1 Eisai Inc Company Information
  15. 6.3.2 Eisai Inc Business Overview
  16. 6.3.3 Eisai Inc Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eisai Inc Levetiracetam Product Portfolio
  18. 6.3.5 Eisai Inc Recent Developments
  19. 6.4 Salubris Pharmaceuticals
  20. 6.4.1 Salubris Pharmaceuticals Company Information
  21. 6.4.2 Salubris Pharmaceuticals Business Overview
  22. 6.4.3 Salubris Pharmaceuticals Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Salubris Pharmaceuticals Levetiracetam Product Portfolio
  24. 6.4.5 Salubris Pharmaceuticals Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Levetiracetam Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Levetiracetam Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Levetiracetam Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Levetiracetam Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 UCB Pharma
  50. 6.9.1 UCB Pharma Company Information
  51. 6.9.2 UCB Pharma Business Overview
  52. 6.9.3 UCB Pharma Levetiracetam Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 UCB Pharma Levetiracetam Product Portfolio
  54. 6.9.5 UCB Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Levetiracetam Sales by Country
  2. 7.1.1 North America Levetiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Levetiracetam Sales by Country (2021-2026)
  4. 7.1.3 North America Levetiracetam Sales Forecast by Country (2027-2032)
  5. 7.2 North America Levetiracetam Market Size by Country
  6. 7.2.1 North America Levetiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Levetiracetam Market Size by Country (2021-2026)
  8. 7.2.3 North America Levetiracetam Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Levetiracetam Sales by Country
  2. 8.1.1 Europe Levetiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Levetiracetam Sales by Country (2021-2026)
  4. 8.1.3 Europe Levetiracetam Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Levetiracetam Market Size by Country
  6. 8.2.1 Europe Levetiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Levetiracetam Market Size by Country (2021-2026)
  8. 8.2.3 Europe Levetiracetam Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Levetiracetam Sales by Country
  2. 9.1.1 Asia-Pacific Levetiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Levetiracetam Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Levetiracetam Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Levetiracetam Market Size by Country
  6. 9.2.1 Asia-Pacific Levetiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Levetiracetam Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Levetiracetam Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Levetiracetam Sales by Country
  2. 10.1.1 South America Levetiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Levetiracetam Sales by Country (2021-2026)
  4. 10.1.3 South America Levetiracetam Sales Forecast by Country (2027-2032)
  5. 10.2 South America Levetiracetam Market Size by Country
  6. 10.2.1 South America Levetiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Levetiracetam Market Size by Country (2021-2026)
  8. 10.2.3 South America Levetiracetam Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Levetiracetam Sales by Country
  2. 11.1.1 Middle East and Africa Levetiracetam Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Levetiracetam Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Levetiracetam Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Levetiracetam Market Size by Country
  6. 11.2.1 Middle East and Africa Levetiracetam Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Levetiracetam Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Levetiracetam Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Levetiracetam Value Chain Analysis
  2. 12.1.1 Levetiracetam Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Levetiracetam Production Mode & Process
  7. 12.2 Levetiracetam Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Levetiracetam Distributors
  10. 12.2.3 Levetiracetam Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst